BEENûAFFECTEDûBYûTRAVELûRESTRICTIONSûANDû
GOVERNMENT
MANDATEDûLOCKDOWNSû
WORLDWIDEûINCLUDINGûINû)NDIAû)$0SûLARGESTû
TESTINGûMARKET
)$0ûHASûDEFERREDûPAYMENTûOFûTHEû!Mû
&9ûû(ûDIVIDENDûTOû3EPTEMBER
Macquarie CapitalûWASûTHEûBOOKRUNNERûOFû
THEûPLACEMENT
-EANWHILEû)$0SûEXISTINGûLENDERSûAREû
PROVIDINGûTHEûCOMPANYûWITHûAû!MûLOANûTOû
LIFTûITSûLIQUIDITYûPOSITIONûTHEûCOMPANYûSAIDûINûAû
lLINGûLASTû7EDNESDAYû4HEû
MONTHûWORKINGû
CAPITALûFACILITYûWILLûADDûTOûANOTHERû!Mû
BORROWINGûTHATûREMAINSûUNDRAWN
CHINA
KANGJI MEDICAL CHOOSES HONG KONG
#HINESEûMEDICALûEQUIPMENTûMAKERûKANGJI
MEDICALûISûPLANNINGûTOûRAISEûABOUTû53Mn
MûFROMûAû(ONGû+ONGû)0/ûTHISûYEARûSAIDû
PEOPLEûCLOSEûTOûTHEûDEAL
4HEûCOMPANYûlLEDûAûLISTINGûAPPLICATIONûONû
-ARCHûûWITHûBank of AmericaûCLSA and
Goldman SachsûASûSPONSORSû.OûFUNDRAISINGû
SIZEûORûTIMETABLEûISûMENTIONEDûINûTHEûlLING
4HEûDEALûCOULDûHITûTHEûMARKETûINûTHEû
SECONDûQUARTERûIFûMARKETûCONDITIONSûALLOWû
SAIDûTHEûPEOPLE
+ANGJIûWHICHûMAKESûEQUIPMENTûFORû
MINIMALLYûINVASIVEûSURGERYûPOSTEDûAûNETû
PROlTûOFû2MBMû53M ûFORûûUPû
ûFROMû
&OUNDEDûINûû+ANGJIûlLEDûAûLISTINGû
APPLICATIONûFORûANû!
SHAREû)0/ûINû*UNEûû
BUTûWITHDREWûITûBECAUSEûOFûTHEûPROLONGEDû
ANDûUNCERTAINûTIMETABLEûOFûTHEûVETTINGû
PROCESSûFORûANû!
SHAREûLISTINGûANDûTOûGAINû
INTERNATIONALûRECOGNITIONûWITHûAû(ONGû+ONGû
LISTING
WUXI BIOLOGICS BLOCK UPSIZED
7U8Iû"IOLOGICSû(OLDINGSûHASûRAISEDû
(+BNû53M ûFROMûANûUPSIZEDûSELL
down in WUXI BIOLOGICS (CAYMAN)
4HEûDEALûWHICHûWASûUPSIZEDûFROMûMûTOû
MûSHARESûWASûPRICEDûATû(+ûPERû
SHAREûFROMûTHEû(+nûRANGE
4HEûlNALûPRICEûREPRESENTSûAûDISCOUNTûOFû
ûTOûTHEûCOMPANYSûCLOSEûOFû(+û
LASTû4UESDAY
4HEûBOOKSûWEREûMULTIPLEûTIMESû
OVERSUBSCRIBEDûWITHûSIGNIlCANTûSUPPORTû
FROMûGLOBALûLONG
ONLYûINVESTORSûANDûEXISTINGû
SHAREHOLDERSû4HEREûWEREûMOREûTHANûû
INVESTORSûINûTHEûBOOKSûANDûALLOCATIONûWASû
HEAVILYûSCALEDûBACKûANDûCONCENTRATEDû4HEû
TOPûûINVESTORSûTOOKûABOUTûûOFûTHEûDEALû
ANDûTHEûTOPûûABOUTû
4HEREûISûAûTHREE
MONTHûLOCK
UP
!FTERûTHEûSALEû7U8Iû"IOLOGICSû(OLDINGSû
REMAINSûTHEûCONTROLLINGûSHAREHOLDERûINû
7U8Iû"IOLOGICSû#AYMAN ûWITHûAûû
STAKE
Morgan Stanley WASûTHEûSOLEûBOOKRUNNER
BROKERAGES OPT FOR RIGHTS ISSUES TO
EXPAND
3HENZHEN
LISTEDûSHANXI SECURITIESûHASûCLEAREDû
AûHEARINGûONûAûPROPOSEDû2MBBNû53M û
RIGHTSûISSUEûATûTHEû#HINAû3ECURITIESû
2EGULATORYû#OMMISSION
4HEûBROKERAGEûWILLûSELLûMûSHARESûONûAû
FOR
ûBASIS
)TûWILLûUSEûTHEûPROCEEDSûTOûEXPANDûITSû
CAPITALûINTERMEDIARYûlXEDûINCOMEûANDûBILLû
INVESTMENTûBUSINESSESûANDûTOûINCREASEûTHEû
CAPITALûOFûAûSUBSIDIARY
4HEûCOMPANYûPOSTEDûûREVENUESûOFû
2MBBNûAûûDECREASEûYEAR
ON
YEARû)Tû
HASûAûûSTAKEûINûITSû:HONGû$Eû3ECURITIESû
*6ûWITHû$EUTSCHEû"ANK
Citic Securities ISûTHEûSPONSOR
3HANGHAI
LISTEDûHONGTA SECURITIESûISûALSOû
PLANNINGûAûRIGHTSûISSUEûTOûRAISEû2MBBN
4HEûBROKERAGEûPLANSûTOûOFFERûBNû
SHARESûONûAû
FOR
ûBASIS
(ALFûOFûTHEûPROCEEDSûWILLûGOûINTOûTHEû&)##û
BUSINESSûWITHûTHEûRESTûUSEDûACROSSûOTHERû
BUSINESSûLINESûFORû)4ûSYSTEMSûANDûAûNEWû
SUBSIDIARY
4HEûCOMPANYûCOMPLETEDûAû2MBBNû
)0/ûLASTû*ULYûSoochow Securities was the
SPONSOR
)TûPOSTEDûAûûNETûPROlTûOFû2MBMû
MOREûTHANûDOUBLEûTHEûPREVIOUSûYEARSûPROlTû
ONûREVENUEûOFû2MBBNûAûûINCREASE
VIVA TRIMS LI NING STAKE
'%-
LISTEDû6IVAû#HINAûHASûRAISEDû(+BNû
53M ûFROMûTHEûSALEûOFûPARTûOFûITSûSTAKEû
INû#HINESEûSPORTSWEARûCOMPANYûLI NING
THROUGHûAûBLOCKûTRADE
4HEûDEALûCOMPRISINGûMûSHARESûORûû
OFûTHEûTOTALûOUTSTANDINGûWASûPRICEDûATûTHEû
TOPûOFûAû(+nûRANGEûORûATûAûû
DISCOUNTûTOûTHEûCOMPANYSûCLOSEûOFû(+û
LASTû4UESDAY
4HEûBOOKSûWEREûHEAVILYûOVERSUBSCRIBEDû
WITHûSTRONGûSUPPORTûFROMûGLOBALûLONG
ONLYûINVESTORSûEXISTINGûSHAREHOLDERSû
SOVEREIGNûWEALTHûFUNDSûANDûHEDGEûFUNDSû
4HEûTOPûlVEûINVESTORSûTOOKûCLOSEûTOûûOFû
THEûDEAL
4HEREûISûAû
DAYûLOCK
UPûONûTHEûSELLER
HSBCûWASûTHEûBOOKRUNNER
International Financing Review April 4 2020 97
EQUITIES ASIA-PACIFIC
ASIA-PACIFIC IPOs
BOOKRUNNERS: 1/1/2020–31/3/2020
Managing No of Total Share
bank or group issues US$(m) (%)
Including all domestic and international deals
Proportional credit
Source: Refinitiv SDC code: C04a6
1 CICC 13 2,464.65 14.9
2 Citic 4 1,623.56 9.8
3 China Securities 6 1,436.85 8.7
4 Sinolink Securities 4 770.82 4.7
5 Bualuang Securities 1 539.74 3.3
6 Kasikornbank PCL 1 539.74 3.3
7 Phatra Securities 1 539.74 3.3
8 UBS 4 487.16 2.9
9 GF Securities 7 482.25 2.9
10 Credit Suisse 4 471.00 2.8
Total 182 16,556.66
ASIA-PACIFIC SECONDARY OFFERINGS
BOOKRUNNERS: 1/1/2020–31/3/2020
Managing No of Total Share
bank or group issues US$(m) (%)
Including all domestic and international deals and rights issues Proportional credit
Source: Refinitiv SDC code: C04a7
1 Morgan Stanley 12 2,948.05 13.2
2 Goldman Sachs 13 1,824.35 8.2
3 China Securities 2 1,712.07 7.7
4 UBS 9 1,297.55 5.8
5 BofA Securities 8 1,228.74 5.5
6 JP Morgan 8 1,026.89 4.6
7 HSBC 7 946.49 4.2
8 Citigroup 4 808.38 3.6
9 Sumitomo Mitsui 15 766.23 3.4
10 Industrial Securities 3 556.48 2.5
Total 278 22,379.58
ASIA-PACIFIC IPOs (EXCLUDING JAPAN)
BOOKRUNNERS: 1/1/2020–31/3/2020
Managing No of Total Share
bank or group issues US$(m) (%)
Including all domestic and international deals
Proportional credit
Source: Refinitiv SDC code: C04a4
1 CICC 13 2,464.65 15.5
2 Citic 4 1,623.56 10.2
3 China Securities 6 1,436.85 9.0
4 Sinolink Securities 4 770.82 4.8
5 Phatra Securities 1 539.74 3.4
6 Bualuang Securities 1 539.74 3.4
7 Kasikornbank PCL 1 539.74 3.4
8 UBS 4 487.16 3.1
9 GF Securities 7 482.25 3.0
10 Credit Suisse 3 439.64 2.8
Total 153 15,947.86
ASIA-PACIFIC SECONDARY OFFERINGS
(EXCLUDING JAPAN)
BOOKRUNNERS: 1/1/2020–31/3/2020
Managing No of Total Share
bank or group issues US$(m) (%)
Including all domestic and international deals and rights issues
Proportional credit
Source: Refinitiv SDC code: C04a5r
1 Morgan Stanley 9 2,754.99 13.6
2 Goldman Sachs 12 1,764.72 8.7
3 China Securities 2 1,712.07 8.4
4 UBS 9 1,297.55 6.4
5 BofA Securities 7 1,200.50 5.9
6 JP Morgan 8 1,026.89 5.1
7 HSBC 7 946.49 4.7
8 Citigroup 4 808.38 4.0
9 Industrial Securities 3 556.48 2.7
10 CICC 5 536.36 2.6
Total 252 20,295.67
10 IFR Equities and SE 2327 p 95 - 106 .indd 97 03 / 04 / 2020 20 : 40 : 33